(Q38131966)

29 August 2017

title

Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases (English)

1 reference

idiopathic inflammatory myopathy

29 August 2017

0 references

1 reference

Ju Ann Tan

1

1 reference

29 August 2017

Peter J Roberts-Thomson

2

1 reference

29 August 2017

Peter Blumbergs

3

1 reference

29 August 2017

Paul Hakendorf

4

1 reference

29 August 2017

Sally R Cox

5

1 reference

29 August 2017

Vidya Limaye

6

1 reference

29 August 2017

publication date

13 October 2011

1 reference

International Journal of Rheumatic Diseases

29 August 2017

published in

1 reference

29 August 2017

volume

16

1 reference

29 August 2017

issue

3

1 reference

29 August 2017

page(s)

331-338

1 reference

Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Polymyositis and dermatomyositis (second of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Inclusion body myositis and myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Polymyositis, dermatomyositis and inclusion-body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Occurrence of polymyositis in the county of Gävleborg, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Prevalence of sporadic inclusion body myositis in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

What determines quality of life in inclusion body myositis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Sporadic inclusion body myositis: a continuing puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Polymyositis: an overdiagnosed entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

The geoepidemiology of autoimmune muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Inclusion body myositis: its relative frequency in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

Inflammatory, immune, and viral aspects of inclusion-body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2011.01669.X

10.1111/J.1756-185X.2011.01669.X

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference